Pfizer Is Trading at Less Than 10 Times Earnings. But Is the Stock Actually Cheap?
Pfizer Inc. (NYSE:PFE) has barely rewarded shareholders over the past year. That underperformance has left Pfizer looking inexpensive. Based on the midpoint of the company’s 2026 adjusted diluted EPS guidance range of $2.80 to $3.00, the stock trades at roughly 9.6 times forward adjusted earnings, according to our calculations. There are nine healthcare stocks that […]
Pfizer Inc. (NYSE:PFE) has barely rewarded shareholders over the past year. That underperformance has left Pfizer looking inexpensive. Based on the midpoint of the company’s 2026 adjusted diluted EPS guidance range of $2.80 to $3.00, the stock trades at roughly 9.6 times forward adjusted earnings, according to our calculations. There are nine healthcare stocks that […]
What's Your Reaction?
